Clinical Data Management White Paper & Articles

  1. Bringing Local Payments To International Clinical Trials 3/18/2026

    Modernize clinical trials by replacing slow international wires with local digital payments. Reduce participant friction and ensure fair, instant reimbursements across the globe.

  2. Top 10 HEOR Trends Report 3/16/2026

    Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

  3. 2026 State Of Clinical Trial Technology: The Five Strategic Imperatives 3/12/2026

    AI acceleration and digital fragmentation are reshaping clinical trials. Discover five imperatives driving interoperability, smarter site enablement, and data‑ready workflows for future‑ready operations.

  4. Rethinking RTSM Software: When Bigger Isn't Better 3/9/2026

    Don’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.

  5. From Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development 3/4/2026

    Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.

  6. The Innovations Shaping 2026 CNS Clinical Trials 2/27/2026

    Explore how AI, digital tools, and site‑centered design can reduce burden, strengthen data quality, and support more reliable trial execution.

  7. RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters 2/25/2026

    Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.

  8. Choosing RTSM? Evaluate The Team Running It, Not Just The Software 2/25/2026

    High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.

  9. Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials 2/24/2026

    A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.

  10. Evaluating Wearable Data Platforms For Endpoint-Driven Studies 2/24/2026

    Endpoint‑driven studies need platforms that unify wearable data with trial systems, support derived measures, and ensure traceability so continuous data becomes reliable clinical evidence.